The State-of-the-Art of Phase II/III Clinical Trials for Targeted Pancreatic Cancer Therapies

Pancreatic cancer is a devastating disease with very poor prognosis. Currently, surgery followed by adjuvant chemotherapy represents the only curative option which, unfortunately, is only available for a small group of patients. The majority of pancreatic cancer cases are diagnosed at advanced or me...

Descripción completa

Detalles Bibliográficos
Autores principales: Garcia-Sampedro, Andres, Gaggia, Gabriella, Ney, Alexander, Mahamed, Ismahan, Acedo, Pilar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7913382/
https://www.ncbi.nlm.nih.gov/pubmed/33546207
http://dx.doi.org/10.3390/jcm10040566

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7913382/
https://www.ncbi.nlm.nih.gov/pubmed/33546207
http://dx.doi.org/10.3390/jcm10040566

Ejemplares similares